Dabrafenib/Trametinib Combo Granted EU Approval for Advanced Melanoma
The combination of dabrafenib (Tafinlar) plus trametinib (Mekinist) has been approved in the EU for advanced melanoma.
ASCO Updates Stage IV NSCLC Treatment Guideline
ASCO has updated their clinical practice guideline for the treatment of patients with stage IV non-small cell lung cancer, placing greater emphasis on the selection of targeted therapies.
Combination Therapies Continue to Advance in Melanoma
Anna Pavlick, DO, discusses immunotherapy and targeted combination regimens in advanced melanoma.
Smart Apps for Smart Docs
Life as a fellow is extremely hectic, and mobile apps can help us save an enormous amount of time when conducting research.
A Word from your Fellows
ICD-10 Codes Are a Brave New World for Oncology Practices
Getting ready for ICD-10 has involved a huge commitment to staff training and also much attention to the finer details.
Oncology Business Management
Precision Medicine Modeling Helps Advance Colorectal Cancer Care
Preclinical mouse models and cell lines link colorectal cancer subtypes subtypes with potential therapies.
Cancer Immunotherapy Meets Precision Medicine in Biomarker Study
Mismatch repair deficiency may serve as an immuno-oncology biomarker and may illustrate the clinical utility of analyzing the number of mutations per tumor.
From the Editor
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2015
Intellisphere, LLC. All Rights Reserved.